Aardvark Therapeutics, Inc. Common Stock (AARD) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 286.44M |
| Enterprise Value | 239.83M |
| P/E Ratio | -1.32 |
| PEG Ratio | 0.02 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 1.06 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -0.43 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.71 |
| Return On Equity | -0.62 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -57.56M |
| Net Income | -57.59M |
| Diluted EPS | -2.64 |
| Total Cash | 91.2M |
| Total Cash/Share | 4.18 |
| Total Debt | 336,000 |
| Total Debt/Equity | 0 |
| Current Ratio | 8.06 |
| Book Value Per Share | 3.99 |
| 52-Week Change | -73.16 |
| 52-Week High | 17.94 |
| 52-Week Low | 3.35 |
| Moving Average 50 Days | 4.71 |
| Moving Average 200 Days | 9.45 |
| Average Volume | 172,303 |
| Shares Outstanding | 21.82M |
| % Held by Institutions | 46.75 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |